176 related articles for article (PubMed ID: 30261884)
1. Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke.
Gainey J; Blum B; Bowie B; Cooley K; Madeline L; Ervin EL; Nathaniel TI
Lipids Health Dis; 2018 Sep; 17(1):226. PubMed ID: 30261884
[TBL] [Abstract][Full Text] [Related]
2. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia.
Blum B; Wormack L; Holtel M; Penwell A; Lari S; Walker B; Nathaniel TI
BMC Womens Health; 2019 Jan; 19(1):11. PubMed ID: 30651099
[TBL] [Abstract][Full Text] [Related]
3. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke.
Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408
[TBL] [Abstract][Full Text] [Related]
5. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients.
Brecthel L; Gainey J; Penwell A; Nathaniel TI
BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762
[TBL] [Abstract][Full Text] [Related]
6. The telestroke and thrombolysis therapy in diabetic stroke patients.
Nathaniel TI; Ubah C; Wormack L; Gainey J
Diabetol Metab Syndr; 2019; 11():36. PubMed ID: 31086570
[TBL] [Abstract][Full Text] [Related]
7. Functional Outcome Measures of Recombinant Tissue Plasminogen Activator-Treated Stroke Patients in the Telestroke Technology.
Gainey J; Brecthtel L; Blum B; Keels A; Madeline L; Lowther E; Nathaniel T
J Exp Neurosci; 2018; 12():1179069518793412. PubMed ID: 30245570
[TBL] [Abstract][Full Text] [Related]
8. Role of dyslipidemia in ischemic stroke patients treated in the telestroke network.
Brechtel L; Poupore N; Monroe M; Knisely K; Sanders C; Edrissi C; Rathfoot C; Nathaniel TI
Adv Med Sci; 2021 Sep; 66(2):254-261. PubMed ID: 33940526
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy.
Knisely K; Sanders CB; Edrissi C; Rathfoot C; Poupore N; Bailey-Taylor MJ; Stewart B; Nathaniel T
J Vasc Nurs; 2022 Jun; 40(2):74-85. PubMed ID: 35750378
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
Nisar T; Hanumanthu R; Khandelwal P
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
[TBL] [Abstract][Full Text] [Related]
11. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity.
Blum B; Penwell A; Wormack L; Walker B; Lari S; Nathaniel TI
Neurol Sci; 2019 Sep; 40(9):1829-1839. PubMed ID: 31049791
[TBL] [Abstract][Full Text] [Related]
12. Impact of Participation in a Telestroke Network on Clinical Outcomes.
Zhang D; Shi L; Ido MS; Green DE; Li Y; Su D; Hess DC
Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e005147. PubMed ID: 30606053
[TBL] [Abstract][Full Text] [Related]
13. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
[TBL] [Abstract][Full Text] [Related]
14. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
[No Abstract] [Full Text] [Related]
15. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy.
Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI
Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression.
Okon M; Blum B; Nathaniel TI
J Vasc Nurs; 2021 Dec; 39(4):91-99. PubMed ID: 34865727
[TBL] [Abstract][Full Text] [Related]
17. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological thrombolysis for acute ischemic stroke treatment: Gender differences in clinical risk factors.
Colello MJ; Ivey LE; Gainey J; Faulkner RV; Johnson A; Brechtel L; Madeline L; Nathaniel TI
Adv Med Sci; 2018 Mar; 63(1):100-106. PubMed ID: 28985592
[TBL] [Abstract][Full Text] [Related]
19. Rural Victorian Telestroke project.
Nagao KJ; Koschel A; Haines HM; Bolitho LE; Yan B
Intern Med J; 2012 Oct; 42(10):1088-95. PubMed ID: 21981424
[TBL] [Abstract][Full Text] [Related]
20. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
